Cargando…
Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification
BACKGROUND: The 2016 World Health Organization (WHO) classification of central nervous system (CNS) tumors has been modified to incorporate the IDH mutation and 1p/19q co-deletion in the diagnosis of diffuse gliomas. In this study, we aimed to evaluate the feasibility and prognostic significance of...
Autores principales: | Ochirjav, Enkhee, Enkhbat, Bayarmaa, Baldandorj, Tuul, Choe, Gheeyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755654/ https://www.ncbi.nlm.nih.gov/pubmed/31370384 http://dx.doi.org/10.4132/jptm.2019.07.15 |
Ejemplares similares
-
Reclassification of Acute Myeloid Leukemia According to the 2016 WHO Classification
por: Jung, Jin, et al.
Publicado: (2019) -
Hematolymphoid tumor of prostate: Diffuse large B cell lymphoma case report
por: Ochirjav, Enkhee, et al.
Publicado: (2023) -
Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification
por: Zakharova, Galina, et al.
Publicado: (2022) -
Prevalence of Y chromosome microdeletions among infertile Mongolian men
por: Damdinsuren, Erdenesuvd, et al.
Publicado: (2022) -
Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016
por: SASAKI, Hikaru, et al.
Publicado: (2017)